Miscellaneous… Autumn 2025 Press Review – Miscellanous 22 Sep 202529 Sep 2025 April 2025 to July 2025 Author: Victoria Konzett Upadacitinib FDA and EMA-approved for treatment of giant cell arteritis after positive results from the SELECT-GCA study Blockmans et al. (10.1056/NEJMoa2413449) compared Upadacitinib…
Miscellaneous… Spring 2025 Press Review – Miscellaneous 12 May 2025 December 2024 to March 2025 Authors: Valentina Pucino and Jacob Koopman A Phase-3 Study on the Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis Furie R, et al. (doi:10.1056/NEJMoa2410965) conducted…
Miscellaneous… Winter 2025 Press Review – Miscellaneous 2 Feb 20254 Feb 2025 August 2024 to November 2024 Author: Aleksandra Opinc-Rosiak and Deniz Bayraktar (Denislav Orlinov) In severe osteoarthritis, total hip replacement is more effective and comparably safe than resistance training Frydenal et al.…
Miscellaneous… Autumn 2024 Press Review – Miscellaneous 8 Oct 20249 Oct 2024 APRIL 2024 to JULY 2024 Author: Daliya Pencheva and Piotr Kuszmiersz AUTUMN 2024 Press Review - Miscellaneous Digital acceptance and commitment therapy for fibromyalgia Gendreau et al. (10.1016/S0140-6736(24)00909-7) conducted a phase 3, multi-centre,…
Miscellaneous… Winter Press Review 2024 – Miscellaneous 10 Jan 2024 August 2023 to November 2023 Author: Victoria Konzett Miscellaneous Sarilumab in polymyalgia rheumatica Spiera et al (doi.org/10.1056/NEJMoa2303452) investigated Sarilumab, an interleukin (IL)-6 blocking monoclonal antibody, for treatment of polymyalgia rheumatica (PMR),…
EMEUNET… MISCELLANEOUS: OTHER RHEUMATOLOGY JOURNALS 12 May 202313 May 2023 December 2022 to March 2023 Authors: Juan C Sarmiento-Monroy Petri M et al (doi: 10.1016/S0140-6736(22)02546-6) assessed the efficacy and safety of baricitinib (BARI) in 775 adult patients with active SLE in a phase 3 study (SLE-BRAVE-II).…
Miscellaneous… Miscellaneous 20 Jan 2023 August to November 2022 Author: Giacomo Cafaro Hannah et al. (doi: 10.3899/jrheum.220383) performed a systematic literature review (SLR) and meta-analysis (MA) to evaluate predictors of mortality in inflammatory myopathy-associated interstitial…